Fig. 3From: Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondentsMonitoring frequency for kidney and heart function. (A) Kidney function. (B) Heart function. ERT, enzyme replacement therapy; FD, Fabry diseaseBack to article page